SU5204

CAS No. 186611-11-0

SU5204( 3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one )

Catalog No. M22955 CAS No. 186611-11-0

SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 In Stock
10MG 67 In Stock
25MG 119 In Stock
50MG 177 In Stock
100MG 284 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU5204
  • Note
    Research use only, not for human use.
  • Brief Description
    SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
  • Description
    SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR2|HER2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186611-11-0
  • Formula Weight
    265.31
  • Molecular Formula
    C17H15NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (376.92 mM)
  • SMILES
    O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Peng Cho Tang, et al. 3-heteroaryl-2-indolinone compounds for the treatment of disease. US5792783A.
molnova catalog
related products
  • UNC0064-12 hydrochlo...

    UNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.

  • SU5204

    SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).

  • Pazopanib

    A potent, orally available, pan-VEGFR inhibitor with IC50 of 10, 30, and 47 nM for VEGFR-1, -2, and -3, respectively.